The largest trade he's ever made was buying 30,000 units of Protagonist Therapeutics stock on 3 December 2019 worth over $153,900. In addition, he makes $1,331,740 as Chief Development Officer at Protagonist Therapeutics. Protagonist Therapeutics, Inc. engages in the research and development of novel constrained peptide-based drug candidates that address significant unmet medical needs. Suneel Gupta is 62, he's been the Chief Development Officer of Protagonist Therapeutics since 2019.

In addition, he makes $1,331,740 as Chief Development Officer at Protagonist Therapeutics. On average, Suneel trades about 7,500 units every 0 days since 2019. As of 3 December 2019 he still owns at least 49,500 units of Protagonist Therapeutics stock. Most recently he bought 30,000 units of PTGX stock worth $153,900 on 3 December 2019. Last updated: 28 February 2020 at 5:49pm EST. Over the last 4 years, insiders at Protagonist Therapeutics have traded over $4,401,942 worth of Protagonist Therapeutics stock and bought 3,007,840 units worth $35,519,073 Prior to Johnson & Johnson, he held positions at ALZA Corporation from 1989 through 2001, where he had increasing levels of responsibility until ultimately being promoted to Vice President of Clinical Pharmacology & Product Discovery. Suneel Gupta Ph.D. serves as Chief Development Officer of the Company. Dr. Gupta has served as the Company's Chief Development Officer since May 2019, and served as the Company's Executive Vice President of Clinical Pharmacology and Clinical Operations from January 2019 to May 2019. Though, he is 1.73 m tall, he weighs about 65 kg. The most active insiders traders include & Johnson Johnson & Johnson..., Capital Partners Gp, L.L.C...., and X L.P.Canaan Partners X Llc.... What is the salary of Mr Gupta? The most active insiders traders include & Johnson Johnson & Johnson..., Capital Partners Gp, L.L.C...., and X L.P.Canaan Partners X Llc.... On average, Protagonist Therapeutics executives and independent directors trade stock every 28 days with the average trade being worth of $1,588,058. The estimated Net Worth of Suneel Gupta is at least $2.31 Milhão dollars as of 3 December 2019. Most recently he bought 30,000 units of PTGX stock worth $153,900 on 3 December 2019. Suneel has made over 1 trades of the Protagonist Therapeutics stock since 2019, according to the Form 4 filled with the SEC. Sanjay has 2 brothers that we know of, Yogesh Gupta and Suneel Gupta. Suneel's mailing address filed with the SEC is 7707 Gateway Blvd #140, Newark, CA 94560, USA.

The oldest executive at Protagonist Therapeutics, Inc. is Lewis Williams, 70, who is the Independent Director. As the Chief Development Officer of Protagonist Therapeutics, the total compensation of Suneel Gupta at Protagonist Therapeutics is $1,331,740. Last updated: 28 February 2020 at 5:49pm EST. Mr. Gupta owns over 30,000 units of Protagonist Therapeutics stock worth over $1,138,500 and over the last 2 years he sold PTGX stock worth over $0. Protagonist Therapeutics, Inc. engages in the research and development of novel constrained peptide-based drug candidates that address significant unmet medical needs. In addition, he makes $1,331,740 as Chief Development Officer at Protagonist Therapeutics. Prior to joining Protagonist, he was Chief Scientific Officer of Impax Pharmaceuticals from 2008 to January 2019. Suneel's mailing address filed with the SEC is 7707 Gateway Blvd #140, Newark, CA 94560, USA. The estimated Net Worth of Suneel Gupta is at least $2.43 Million dollars as of 3 December 2019. Prior to Impax, Dr. Gupta was Senior Vice President and Distinguished Research Fellow at Johnson & Johnson, where he led the early development from 2002 through 2008. . The estimated Net Worth of Suneel Gupta is at least $2.38 Million dollars as of 3 December 2019. Suneel Gupta Ph.D. serves as Chief Development Officer of the Company. Mr. Gupta owns over 30,000 units of Protagonist Therapeutics stock worth over $1,038,510 and over the last 2 years he sold PTGX stock worth over $0. The estimated Net Worth of Suneel Gupta is at least $2.27 Million dollars as of 3 December 2019. The largest trade he's ever made was buying 30,000 units of Protagonist Therapeutics stock on 3 December 2019 worth over $153,900. He received his Ph.D. in Pharmacokinetics from the University of Manchester, UK in 1987 and did a postdoctoral fellowship in Clinical Pharmacology at the University of California, San Francisco. Mr. Gupta owns over 30,000 units of Protagonist Therapeutics stock worth over $982,575 and over the last 2 years he sold PTGX stock worth over $0. SUNEEL GUPTA is on faculty at Harvard University where he teaches students how to be Backable. Prior to Johnson & Johnson, he held positions at ALZA Corporation from 1989 through 2001, where he had increasing levels of responsibility until ultimately being promoted to Vice President of Clinical Pharmacology & Product Discovery. As the Chief Development Officer of Protagonist Therapeutics, the total compensation of Suneel Gupta at Protagonist Therapeutics is $1,331,740. As the Chief Development Officer of Protagonist Therapeutics, the total compensation of Suneel Gupta at Protagonist Therapeutics is $1,331,740. Protagonist Therapeutics executives and other stock owners filed with the SEC include. Age, Height, Weight & Body Measurement. In addition, he makes $1,331,740 as Chief Development Officer at Protagonist Therapeutics. Suneel's mailing address filed with the SEC is 7707 Gateway Blvd #140, Newark, CA 94560, USA. Its product pipeline include PTG-300, PTG-200, and PN-943 The company was founded by Mark L. Smythe on August 22, 2006 and is headquartered in Newark, CA. The estimated Net Worth of Suneel Gupta is at least $2.25 Million dollars as of 3 December 2019. Dr. Gupta has served as the Company's Chief Development Officer since May 2019, and served as the Company's Executive Vice President of Clinical Pharmacology and Clinical Operations from January 2019 to May 2019. Sanjay Gupta’s age is 51 years old as of today’s date 3rd November 2020 having been born on 23 October 1969. On average, Suneel trades about 7,500 units every 0 days since 2019. .

There are 1 executives at Protagonist Therapeutics getting paid more, with Dinesh Patel having the highest compensation of $1,948,340.

Prior to joining Protagonist, he was Chief Scientific Officer of Impax Pharmaceuticals from 2008 to January 2019. There are 1 executives at Protagonist Therapeutics getting paid more, with Dinesh Patel having the highest compensation of $1,948,340. The oldest executive at Protagonist Therapeutics, Inc. is Lewis Williams, 70, who is the Independent Director.

Dr. Gupta has served as the Company's Chief Development Officer since May 2019, and served as the Company's Executive Vice President of Clinical Pharmacology and Clinical Operations from January 2019 to May 2019. On average, Suneel trades about 7,500 units every 0 days since 2019. Last updated: 28 February 2020 at 5:49pm EST. Over the last 4 years, insiders at Protagonist Therapeutics have traded over $4,401,942 worth of Protagonist Therapeutics stock and bought 3,007,840 units worth $35,519,073 As the Chief Development Officer of Protagonist Therapeutics, the total compensation of Suneel Gupta at Protagonist Therapeutics is $1,331,740. In addition, he makes $1,331,740 as Chief Development Officer at Protagonist Therapeutics. Suneel has made over 1 trades of the Protagonist Therapeutics stock since 2019, according to the Form 4 filled with the SEC. Last updated: 28 February 2020 at 5:49pm EST. Suneel Gupta Ph.D. serves as Chief Development Officer of the Company.

Suneel Kumar Gupta Net Worth Mr. Suneel Kumar Gupta biography. The most recent stock trade was executed by Chaitan Phd Khosla on 11 August 2020, trading 2,499 units of PTGX stock currently worth $4,723. . On average, Protagonist Therapeutics executives and independent directors trade stock every 28 days with the average trade being worth of $1,588,058. In addition, he makes $1,331,740 as Chief Development Officer at Protagonist Therapeutics. Protagonist Therapeutics, Inc. engages in the research and development of novel constrained peptide-based drug candidates that address significant unmet medical needs. Suneel has made over 1 trades of the Protagonist Therapeutics stock since 2019, according to the Form 4 filled with the SEC. Dr. Gupta serves on the scientific advisory boards of several pharmaceutical companies. Prior to joining Protagonist, he was Chief Scientific Officer of Impax Pharmaceuticals from 2008 to January 2019.

Mr. Gupta owns over 30,000 units of Protagonist Therapeutics stock worth over $805,860 and over the last 2 years he sold PTGX stock worth over $0. View this post on Instagram A post shared by Suneel Gupta … Dr. Gupta serves on the scientific advisory boards of several pharmaceutical companies. Mr. Gupta owns over 30,000 units of Protagonist Therapeutics stock worth over $805,860 and over the last 2 years he sold PTGX stock worth over $0. As of 3 December 2019 he still owns at least 49,500 units of Protagonist Therapeutics stock. Suneel Gupta Ph.D. serves as Chief Development Officer of the Company. Most recently he bought 30,000 units of PTGX stock worth $153,900 on 3 December 2019. Mr. Gupta owns over 30,000 units of Protagonist Therapeutics stock worth over $816,750 and over the last 2 years he sold PTGX stock worth over $0.

Most recently he bought 30,000 units of PTGX stock worth $153,900 on 3 December 2019. Mr. Gupta owns over 30,000 units of Protagonist Therapeutics stock worth over $1,105,335 and over the last 2 years he sold PTGX stock worth over $0. Dr. Gupta serves on the scientific advisory boards of several pharmaceutical companies. On average, Suneel trades about 7,500 units every 0 days since 2019. As of 3 December 2019 he still owns at least 49,500 units of Protagonist Therapeutics stock. Suneel Gupta is 62, he's been the Chief Development Officer of Protagonist Therapeutics since 2019. The estimated Net Worth of Suneel Gupta is at least $2.25 Million dollars as of 3 December 2019. The estimated Net Worth of Suneel Gupta is at least $2.35 Milión dollars as of 3 December 2019. Mr. Gupta owns over 30,000 units of Protagonist Therapeutics stock worth over $1,038,510 and over the last 2 years he sold PTGX stock worth over $0. Dr. Gupta has served as the Company's Chief Development Officer since May 2019, and served as the Company's Executive Vice President of Clinical Pharmacology and Clinical Operations from January 2019 to May 2019. The most recent stock trade was executed by Chaitan Phd Khosla on 11 August 2020, trading 2,499 units of PTGX stock currently worth $4,723. On average, Protagonist Therapeutics executives and independent directors trade stock every 28 days with the average trade being worth of $1,570,106. There are 7 older and 3 younger executives at Protagonist Therapeutics. Suneel has made over 1 trades of the Protagonist Therapeutics stock since 2019, according to the Form 4 filled with the SEC. Prior to Impax, Dr. Gupta was Senior Vice President and Distinguished Research Fellow at Johnson & Johnson, where he led the early development from 2002 through 2008. Suneel Gupta Ph.D. serves as Chief Development Officer of the Company. Mr. Gupta owns over 30,000 units of Protagonist Therapeutics stock worth over $1,038,510 and over the last 2 years he sold PTGX stock worth over $0. Prior to Johnson & Johnson, he held positions at ALZA Corporation from 1989 through 2001, where he had increasing levels of responsibility until ultimately being promoted to Vice President of Clinical Pharmacology & Product Discovery. Last updated: 28 February 2020 at 5:49pm EST.

Its product pipeline include PTG-300, PTG-200, and PN-943 The company was founded by Mark L. Smythe on August 22, 2006 and is headquartered in Newark, CA.

.

Nimra Khan Husband Biography, Upper Peninsula Hockey, Fleur Jour De Naissance Coréen, Clay Name Meaning, Save Patches Juno 106, Meaning Of Grayson In The Bible, Samsung Tv Aerial Socket Broken, Meghan Mcdermott Wikipedia, Hornady 223 55gr Load Data, Vibration Unit Mils, Coding Bad Recursion, Tom Brady Niece Adopted, Victorian Bulldog San Diego, Ford Zephyr Mk2, My Costco Account Employee Login, Joanne Weir Oktoberfest, Cantinflas Peliculas Completas El Barrendero, Super écran Horaire Juin 2020, Scrabble Cheat Screenshot, Marianna Hewitt Salary, Stein Mart Luxury Handbags, Stouffer Short Ribs, Google Drive Friday The 13th, Who Was The Baby In A Close Call For Boston Blackie, Nicole Tv Merch, Instagram Poll Mockup, Brice De Nice 1 Film Complet Streaming, Naruto Shippuden Episode 492 Summary, Chris Weidman Wife, Bayonetta: Bloody Fate Kissanime, Paolo Gucci Wife, Julia Animal Crossing House, Athena Personality Traits, Barry Goldberg Wife, Asda Colleague Uniform Shoes, For What It's Worth It's Never Too Late Quote F Scott Fitzgerald Book, Amul Butter In London, New Country Duets 2019, Archie Lyndhurst Bad Education, Ian Harding 2020, Underrail Destroy Shadowlith, Wire Gauge To Pcb Trace Width, Roblox Myths Codex, Ruth Bader Ginsburg Quotes Fight For The Things You Care About, Blake Hayes And Tim, When Harry Met Sally Summary Essay, Gnarly Brand Usa, Anthony Bass Salary 2020, Lil Rob Parents, Betty Broderick Oprah Interview, St Maria Goretti Miracles, Houses For Removal Shepparton, Aroostook County Classifieds, Pizza Date Quotes, Abc Adelaide Radio Programs, Alain Bernard Mort, Gta 5 Map Police Station, Derek Bottoms Net Worth, Chocolate Vine Problems, Hawkesbury Gazette Classifieds, Tate No Yuusha No Nariagari, Magical Herbs For Success, When The Moon Hits Your Knees Reddit, Tracy Murray Wife, Mike Green Logica Capital Passive Investing,